Malignant pleural mesothelioma: an epidemiological perspective

被引:217
|
作者
Robinson, Benjamin M. [1 ]
机构
[1] Baird Inst Appl Heart & Lung Surg Res, Sydney, NSW, Australia
关键词
Asbestos; epidemiology; incidence; malignant mesothelioma;
D O I
10.3978/j.issn.2225-319X.2012.11.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the aetiology, distribution and projected future incidence of malignant mesothelioma. Asbestos exposure is the most thoroughly established risk factor. Debate continues regarding the relative importance of the different asbestos fibre types and the contribution of Simian virus 40 (SV40). Disease incidence varies markedly within and between countries. The highest annual rates of disease, approximately 30 case per million, are reported in Australia and Great Britain. The risk of disease increases with age and is higher in men. Time from asbestos exposure to disease diagnosis is on average greater than 40 years. Nonoccupational asbestos exposures contribute an increasing proportion of disease. With the exception of the United States, incidence continues to increase. In developed countries peak incidence is expected to occur before 2030.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 50 条
  • [31] Clinical diagnosis of malignant pleural mesothelioma
    Bianco, Andrea
    Valente, Tullio
    De Rimini, Maria Luisa
    Sica, Giacomo
    Fiorelli, Alfonso
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S253 - S261
  • [32] Causes and pathophysiology of malignant pleural mesothelioma
    Jean, Didier
    Jaurand, Marie-Claude
    LUNG CANCER MANAGEMENT, 2015, 4 (05) : 219 - 229
  • [33] Malignant pleural mesothelioma: A case report
    Patel, SN
    Kettner, NW
    JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS, 2005, 28 (09) : 724 - 729
  • [34] Brain metastases in malignant pleural mesothelioma
    Yamagishi, Tomoko
    Fujimoto, Nobukazu
    Miyamoto, Yosuke
    Asano, Michiko
    Fuchimoto, Yasuko
    Wada, Sae
    Kitamura, Kenichi
    Ozaki, Shinji
    Nishi, Hideyuki
    Kishimoto, Takumi
    CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (03) : 231 - 237
  • [35] Modern management of malignant pleural mesothelioma
    Patel, Shivani C.
    Dowell, Jonathan E.
    LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 63 - 72
  • [36] Current insights in malignant pleural mesothelioma
    Bard, M
    Debrosse, D
    Caliandro, R
    Girard, P
    Grunenwald, D
    Ruffié, P
    BULLETIN DU CANCER, 2002, 89 (01) : 67 - 74
  • [37] Spontaneous regression of malignant pleural mesothelioma
    Kawanishi R.
    Ueoka H.
    Tabata M.
    Shibayama T.
    Yano T.
    Matsushita A.
    Chikamori K.
    Kohara H.
    Harada M.
    Ohnoshi T.
    International Journal of Clinical Oncology, 1997, 2 (2) : 118 - 120
  • [38] MALIGNANT PLEURAL MESOTHELIOMA - A SURVIVAL STUDY
    HARVEY, JC
    FLEISCHMAN, EH
    KAGAN, AR
    STREETER, OE
    JOURNAL OF SURGICAL ONCOLOGY, 1990, 45 (01) : 40 - 42
  • [39] Early detection of malignant pleural mesothelioma
    Hussein F. Mahmoud
    Egyptian Journal of Bronchology, 2014, 8 (1) : 1 - 9
  • [40] Diagnostic biomarkers of malignant pleural mesothelioma
    Rodriguez Portal, Jose Antonio
    MEDICINA CLINICA, 2009, 133 (12): : 464 - 466